HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Günther Gastl Selected Research

hexylamine

4/2008Biological effect of mono- and dinuclear alkylamine platinum(II) compounds on human lymphoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Günther Gastl Research Topics

Disease

15Neoplasms (Cancer)
09/2018 - 01/2002
7BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2017 - 01/2008
6Infections
09/2011 - 10/2003
5Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 01/2002
5Graft vs Host Disease (Graft-Versus-Host Disease)
08/2007 - 06/2002
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
09/2015 - 06/2004
4Lymphoma (Lymphomas)
05/2011 - 04/2008
3Multiple Myeloma
12/2020 - 06/2004
3Leukemia
05/2008 - 03/2004
3Breast Neoplasms (Breast Cancer)
01/2004 - 04/2002
2Primary Myelofibrosis (Myelosclerosis)
09/2018 - 05/2017
2Thrombosis (Thrombus)
03/2018 - 04/2003
2Essential Thrombocythemia
06/2015 - 06/2015
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2014 - 08/2008
2Invasive Fungal Infections
09/2012 - 12/2008
2Neutropenia
09/2012 - 09/2011
2Hematologic Neoplasms (Hematological Malignancy)
02/2010 - 12/2008
2Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2008 - 06/2004
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2005 - 04/2003
2Cytomegalovirus Infections (Inclusion Disease)
10/2003 - 01/2003
1Chromosome Aberrations (Chromosome Abnormalities)
12/2020
1Renal Cell Carcinoma (Grawitz Tumor)
05/2018
1Wilms Tumor (Wilm's Tumor)
10/2017
1Osteoradionecrosis
01/2016
1Paraproteinemias (Monoclonal Gammopathy)
09/2013
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
09/2013
1Proteinuria
09/2013
1Amyloidosis
09/2013
1Monoclonal Gammopathy of Undetermined Significance
09/2013
1Breakthrough Infections
09/2012
1Thyroid Neoplasms (Thyroid Cancer)
06/2012
1Hemorrhage
02/2012
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
02/2012
1Thrombocytopenia (Thrombopenia)
09/2011
1Exanthema (Rash)
09/2011
1Fanconi Anemia (Fanconi's Anemia)
11/2008
1Rectal Neoplasms (Rectal Cancer)
08/2008
1Glioma (Gliomas)
04/2008
1Necrosis
04/2008
1Melanoma (Melanoma, Malignant)
04/2008

Drug/Important Bio-Agent (IBA)

3anagrelide (Agrylin)FDA LinkGeneric
03/2018 - 01/2014
3Tyrosine Kinase InhibitorsIBA
01/2017 - 06/2012
3fludarabineIBA
05/2008 - 10/2003
2Immunoglobulins (Immunoglobulin)IBA
12/2020 - 09/2013
2ruxolitinibIBA
09/2018 - 05/2017
2Biomarkers (Surrogate Marker)IBA
05/2018 - 01/2016
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 01/2002
2EnzymesIBA
05/2017 - 10/2007
2Bendamustine HydrochlorideFDA Link
09/2015 - 05/2011
2Biological ProductsIBA
09/2013 - 04/2008
2Peptides (Polypeptides)IBA
01/2013 - 03/2004
2VaccinesIBA
01/2013 - 01/2012
2Alemtuzumab (Campath)FDA Link
09/2011 - 11/2006
2Proteins (Proteins, Gene)FDA Link
01/2011 - 04/2008
2Complement System Proteins (Complement)IBA
10/2010 - 04/2002
2AntigensIBA
06/2009 - 06/2002
2N 30IBA
08/2008 - 04/2008
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
02/2004 - 09/2002
1Phosphotransferases (Kinase)IBA
09/2018
1NivolumabIBA
05/2018
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2018
1Bevacizumab (Avastin)FDA Link
01/2018
1Hemostatics (Antihemorrhagics)IBA
06/2015
1Troponin IIBA
06/2015
1pro-brain natriuretic peptide (1-76)IBA
06/2015
1posaconazoleFDA Link
09/2012
1TriazolesIBA
09/2012
1Proteasome InhibitorsIBA
06/2012
1Bortezomib (Velcade)FDA Link
06/2012
1Imatinib Mesylate (Gleevec)FDA Link
06/2012
1nilotinibFDA Link
06/2012
1Inosine Triphosphate (ITP)IBA
02/2012
1InterferonsIBA
01/2012
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2012
1Rituximab (Mabthera)FDA Link
05/2011
1Therapeutic UsesIBA
05/2011
1LigandsIBA
02/2010
1Proteoglycans (Proteoglycan)IBA
08/2009
1myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA
08/2009
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
06/2009
1HLA-A*02:01 antigenIBA
01/2009
1Cytarabine (Cytosar-U)FDA LinkGeneric
05/2008
1AlkanesIBA
04/2008
1Cisplatin (Platino)FDA LinkGeneric
04/2008
1ChloridesIBA
04/2008
1n-dodecaneIBA
04/2008
1hexylamineIBA
04/2008
1nonaneIBA
04/2008
1ethylenediamine (ethylenediamine dihydroiodide)FDA Link
04/2008
1HexanesIBA
04/2008

Therapy/Procedure

13Therapeutics
09/2018 - 09/2004
8Stem Cell Transplantation
10/2017 - 06/2002
7Drug Therapy (Chemotherapy)
10/2017 - 06/2002
4Immunotherapy
05/2018 - 01/2012
4Hematopoietic Stem Cell Transplantation
02/2010 - 05/2008
2Transplantation
02/2010 - 10/2003
1Radiotherapy
01/2016
1Retreatment
09/2011
1Investigational Therapies (Experimental Therapy)
05/2008
1Salvage Therapy
05/2008